News headlines about Innophos Holdings (NASDAQ:IPHS) have trended positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innophos Holdings earned a media sentiment score of 0.27 on Accern’s scale. Accern also assigned news coverage about the specialty chemicals company an impact score of 47.5839939172381 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the news articles that may have impacted Accern’s scoring:

Several equities research analysts have recently weighed in on IPHS shares. Zacks Investment Research raised shares of Innophos Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. BidaskClub downgraded shares of Innophos Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Finally, KeyCorp reissued a “hold” rating on shares of Innophos Holdings in a research report on Wednesday.

Innophos Holdings (IPHS) traded down $0.72 on Friday, hitting $45.32. 103,075 shares of the stock traded hands, compared to its average volume of 95,892. The company has a market cap of $885.05, a P/E ratio of 18.42 and a beta of 0.88. Innophos Holdings has a one year low of $41.66 and a one year high of $58.22. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.86 and a quick ratio of 1.73.

Innophos Holdings (NASDAQ:IPHS) last released its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.06. Innophos Holdings had a net margin of 6.19% and a return on equity of 13.90%. The company had revenue of $184.00 million during the quarter, compared to the consensus estimate of $179.33 million. During the same quarter in the previous year, the firm earned $0.69 EPS. The company’s revenue was down 1.1% on a year-over-year basis. sell-side analysts expect that Innophos Holdings will post 2.5 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be issued a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 4.24%. The ex-dividend date of this dividend is Thursday, November 16th. Innophos Holdings’s dividend payout ratio (DPR) is presently 88.48%.

TRADEMARK VIOLATION NOTICE: This report was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at

Innophos Holdings Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Insider Buying and Selling by Quarter for Innophos Holdings (NASDAQ:IPHS)

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.